VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TVTX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TVTXTravere Therapeutics, Inc.
$58.30$5.4B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTVTXQuarterly Financials

Travere Therapeutics, Inc. (TVTX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Travere Therapeutics, Inc. (TVTX) quarterly income statement — complete revenue, gross profit & net income history

TVTX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue127.2M129.69M164.86M114.45M81.73M74.79M62.9M54.12M41.37M45.06M37.09M32.2M56.99M55.87M28.07M54.17M48.49M57.25M68.22M54.62M
Revenue Growth %55.63%73.41%162.11%111.49%97.54%65.98%69.56%68.08%-27.41%-19.35%32.13%-40.56%17.54%-2.41%-58.84%-0.82%2.28%12.29%33.4%12.78%
Cost of Goods Sold02.55M1.58M1.52M4.68M2.55M1.63M12.41M1.5M16.42M1.29M1.45M5.13M1.73M7.27M2.05M2.14M1.9M1.59M1.65M
COGS % of Revenue-1.97%0.96%1.33%5.72%3.41%2.59%22.92%3.64%36.43%3.47%4.51%8.99%3.09%25.88%3.79%4.41%3.31%2.33%3.02%
Gross Profit0127.14M163.27M112.93M77.05M72.23M61.27M41.71M39.87M28.64M35.81M30.74M51.87M54.14M20.81M52.12M46.35M55.35M66.63M52.97M
Gross Margin %-98.03%99.04%98.67%94.28%96.59%97.41%77.08%96.36%63.57%96.53%95.49%91.01%96.91%74.12%96.21%95.59%96.69%97.67%96.98%
Gross Profit Growth %-100%76.01%166.47%170.75%93.26%152.19%71.12%35.67%-23.13%-47.09%72.07%-41.01%11.91%-2.19%-68.77%-1.6%1.28%13.17%33.38%12.85%
Operating Expenses164.11M159.56M138.34M125.58M119.73M132.97M117.42M108.76M179.11M111.48M128.39M134.69M132.16M120.99M103.41M117.57M103.4M102.54M98.34M88.28M
OpEx % of Revenue129.02%123.04%83.92%109.72%146.49%177.8%186.68%200.98%432.9%247.41%346.11%418.36%231.88%216.57%368.35%217.05%213.25%179.12%144.15%161.64%
Selling, General & Admin80.25M101.69M86.45M76.22M72.84M69.5M65.62M54.43M64.22M52.73M67.8M68.2M72.25M62.92M52.42M52.98M46.79M42.08M36.06M34.97M
SG&A % of Revenue63.09%78.41%52.44%66.59%89.12%92.93%104.33%100.58%155.23%117.03%182.78%211.84%126.76%112.62%186.71%97.81%96.5%73.49%52.87%64.02%
Research & Development57.09M57.87M51.89M49.36M46.89M62.07M51.68M54.33M114.63M58.75M60.59M66.49M59.91M60.23M57.15M59.68M56.61M62.17M48.41M51.81M
R&D % of Revenue44.89%44.62%31.48%43.13%57.37%82.99%82.16%100.4%277.05%130.38%163.34%206.52%105.12%107.81%203.54%110.18%116.76%108.59%70.96%94.86%
Other Operating Expenses1000K00001000K123K0259K00087K-1000K-1000K1000K26K-1000K1000K1000K
Operating Income-36.6M-32.43M24.93M-12.65M-42.67M-60.74M-56.15M-67.05M-139.24M-82.84M-92.58M-103.95M-80.29M-66.85M-82.6M-65.45M-57.05M-47.19M-31.71M-35.31M
Operating Margin %-28.78%-25%15.12%-11.05%-52.21%-81.21%-89.27%-123.9%-336.53%-183.85%-249.59%-322.87%-140.88%-119.66%-294.23%-120.83%-117.66%-82.43%-46.49%-64.66%
Operating Income Growth %14.23%46.61%144.4%81.13%69.35%26.68%39.35%35.5%-73.42%-23.92%-12.08%-58.82%-40.74%-41.66%-160.49%-85.33%-19.98%60.19%-63.16%-52.81%
EBITDA-36.6M-14.29M40.72M1.37M-29.87M-48.64M-44.91M-56.71M-129.36M-70.99M-81.11M-93M-70.75M-57.55M-76.45M-57.34M-49.96M-41.14M-23.84M-28.7M
EBITDA Margin %-28.78%-11.02%24.7%1.19%-36.55%-65.04%-71.4%-104.79%-312.65%-157.54%-218.65%-288.87%-124.13%-103.01%-272.31%-105.86%-103.03%-71.86%-34.94%-52.54%
EBITDA Growth %-22.53%70.62%190.67%102.41%76.91%31.47%44.63%39.03%-82.85%-23.35%-6.09%-62.19%-41.61%-39.89%-220.71%-99.84%-20.45%63.24%-83.43%-66.25%
D&A (Non-Cash Add-back)018.14M15.79M14.02M12.8M12.09M11.24M10.35M9.88M11.85M11.47M10.95M9.54M9.3M6.15M8.11M7.09M6.05M7.87M6.62M
EBIT0-18.77M28.46M-9.89M-38.33M-57.52M-52.06M-66.78M-132.97M-85.71M-86.41M-99.02M-93.64M-62.86M-82.6M-64.01M-73.4M-46.5M-30.7M-34.11M
Net Interest Income0296K296K441K938K978K793K1.63M3.23M4.33M3.02M2.29M796K219K-728K-2.19M-2.24M-4.83M-4.54M-3.86M
Interest Income2.58M2.59M3.05M3.29M3.79M3.79M3.57M4.42M6.03M7.15M5.84M5.13M3.65M3.12M2.1M782K278K236K360K988K
Interest Expense-2.3M2.3M2.75M2.85M2.86M2.82M2.78M2.79M2.8M2.82M2.82M2.84M2.85M2.9M2.83M2.97M2.52M5.07M4.9M4.85M
Other Income/Expense-120K11.36M783K-85K1.49M397K1.31M-2.52M3.47M-5.69M3.36M2.08M-16.2M1.09M-1.31M-1.53M-18.87M-4.38M-3.88M-3.65M
Pretax Income-36.72M-21.07M25.71M-12.73M-41.19M-60.34M-54.84M-69.57M-135.77M-88.53M-89.23M-101.87M-96.49M-65.76M-83.92M-66.98M-75.92M-51.57M-35.6M-38.96M
Pretax Margin %-28.87%-16.24%15.6%-11.13%-50.39%-80.68%-87.18%-128.55%-328.15%-196.47%-240.54%-316.4%-169.29%-117.71%-298.91%-123.65%-156.58%-90.08%-52.18%-71.34%
Income Tax120K921K8K20K39K-72K-84K85K191K68K12K65K78K63K145K53K52K4K43K49K
Effective Tax Rate %-0.33%-4.37%0.03%-0.16%-0.09%0.12%0.15%-0.12%-0.14%-0.08%-0.01%-0.06%-0.08%-0.1%-0.17%-0.08%-0.07%-0.01%-0.12%-0.13%
Net Income-37.1M2.73M25.71M-12.76M-41.23M-60.26M-54.81M-70.41M-136.06M-90.17M150.74M-85.63M-86.33M-65.82M-69.66M-67.03M-75.97M-51.57M-35.64M-39.01M
Net Margin %-29.17%2.1%15.59%-11.14%-50.44%-80.58%-87.14%-130.11%-328.86%-200.12%406.35%-265.96%-151.48%-117.82%-248.11%-123.75%-156.68%-90.09%-52.24%-71.43%
Net Income Growth %10%104.53%146.9%81.88%69.7%33.17%-136.36%17.78%-57.6%-36.99%316.4%-27.74%-13.64%-27.63%-95.45%-71.82%-41.03%57.6%-58.05%-49.65%
Net Income (Continuing)-37.1M-21.99M25.71M-12.76M-41.23M-60.27M-54.75M-69.65M-135.96M-88.6M-89.24M-101.93M-96.56M-65.82M-84.06M-67.03M-75.97M-51.57M-35.64M-39.01M
Discontinued Operations01000K0004K-59K-757K-103K-1000K1000K1000K1000K01000K00000
Minority Interest00000000000000000000
EPS (Diluted)-0.40-0.240.25-0.14-0.47-0.73-0.70-0.91-1.76-1.18-0.99-1.13-1.27-1.03-1.09-1.05-1.20-0.84-0.59-0.64
EPS Growth %14.89%67.12%135.71%84.62%73.3%38.14%29.29%19.47%-38.58%-14.56%9.17%-7.62%-5.83%-22.62%-84.75%-64.06%-25%64.56%-34.09%-10.34%
EPS (Basic)-0.40-0.240.29-0.14-0.47-0.73-0.70-0.91-1.76-1.18-0.99-1.13-1.27-1.03-1.09-1.05-1.20-0.84-0.59-0.64
Diluted Shares Outstanding91.87M90.29M102.62M88.95M88.36M83.11M77.78M77.5M77.14M76.47M76.31M76M68.17M64.21M64.03M63.64M63.13M61.62M60.8M60.57M
Basic Shares Outstanding91.87M90.29M89.23M88.95M88.36M83.11M77.78M77.5M77.14M76.47M76.31M76M68.17M64.21M64.03M63.64M63.13M61.62M60.41M60.57M
Dividend Payout Ratio--------------------